BioVie holds annual shareholder meeting
BIVI•BioVie shareholders approved increasing the shares available under its 2019 Omnibus Equity Incentive Plan from 399,509 to 3.1 million at the November 10 annual meeting.
1. Shareholder votes
Shareholders elected all six director nominees and ratified EisnerAmper LLP’s appointment as independent auditor for the fiscal year ending June 30, 2027. They also approved expanding the 2019 Omnibus Equity Incentive Plan, increasing the Class A common shares available for issuance from 399,509 to 3,100,000.
